Previous Article | Next Article ![]()
Molecular and Cellular Biology, January 1999, p. 376-383, Vol. 19, No. 1
Department of Biochemistry and Molecular
Genetics, University of Colorado Health Sciences Center, Denver,
Colorado 80262,1 and
Department of
Biology, Indiana University, Bloomington, Indiana
474052
Received 6 July 1998/Returned for modification 9 September
1998/Accepted 16 September 1998
Many Caenorhabditis elegans genes exist in operons in
which polycistronic precursors are processed by cleavage at
the 3' ends of upstream genes and trans splicing 100 to 400 nucleotides away, at the 5' ends of downstream genes, to
generate monocistronic messages. Of the two spliced leaders, SL1 is
trans spliced to the 5' ends of upstream genes, whereas SL2
is reserved for downstream genes in operons. However, there are
isolated examples of what appears to be a different sort of operon, in
which trans splicing is exclusively to SL1 and there is no
intercistronic region; the polyadenylation signal is only a few base
pairs upstream of the trans-splice site. We have analyzed
the processing of an operon of this type by inserting the central part
of mes-6/cks-1 into an SL2-type operon. In this novel
context, cks-1 is trans spliced only to SL1,
and mes-6 3'-end formation occurs normally, demonstrating that this unique mode of processing is indeed intrinsic to this kind of
operon, which we herein designate "SL1-type." An exceptionally long
polypyrimidine tract found in the 3' untranslated regions of the
three known SL1-type operons is shown to be required for the
accumulation of both upstream and downstream mRNAs. Mutations of the
trans-splice and poly(A) signals indicate that the two processes are independent and in competition, presumably due to their
close proximity, raising the possibility that production of upstream
and downstream mRNAs is mutually exclusive.
Caenorhabditis elegans is
unusual among eukaryotes in that a significant number of its genes are
arranged in operons (23, 29). Typically, an
operon may contain from two to more than six genes, and the
intercistronic space is 100 to 400 nucleotides (nt). Polycistronic
precursor RNAs are processed by a combination of trans
splicing at the 5' ends of genes and cleavage and polyadenylation at
the 3' ends to generate monocistronic mRNAs (23). There
are two 22-nt spliced leaders, SL1 and SL2, which are trans
spliced to the 5' ends of mRNAs. SL1 is the more abundant spliced
leader and is trans spliced primarily to the 5' ends of
monocistronic RNAs and to upstream genes in operons, although
it is also sometimes found on the 5' ends of downstream genes in
operons as well. In contrast, SL2 is trans spliced
exclusively to downstream genes in operons (29). The
trans-splice signal is identical to the signal for a 3'
splice site (UUUUCAG/R) and differs only in that it lacks a
complementary upstream 5' splice signal (8). The signals for
SL1 and SL2 trans splicing differ only in their contexts; SL2 trans-splice signals lie downstream of another gene, and
SL1 trans-splice signals lie downstream of AU-rich
intron-like sequences called outrons (7).
While little is known about 3'-end formation in C. elegans, it seems likely to occur by a mechanism similar to that
in other animals. The vast majority of C. elegans genes
have a match to the AAUAAA polyadenylation signal at their
3' ends (2), and homologs of many of the mammalian factors,
including subunits of the cleavage and polyadenylation specificity
factor (CPSF) and the cleavage stimulation factor (CstF), have been
identified by the genome sequencing project (28). In
mammals, CPSF has been shown to recognize the AAUAAA signal,
while CstF binds to a GU-rich sequence downstream of the cleavage
site. CPSF is required for both cleavage and polyadenylation in vitro,
while CstF is necessary only for the cleavage step. These two factors
interact and recruit the cleavage factors and poly(A) polymerase to the cleavage site (see reference 6 for a review).
In 1994 Hengartner and Horvitz (10) reported cloning the
cyt-1/ced-9 operon. Intriguingly, although
ced-9 is the downstream gene in this operon, it
is trans spliced exclusively to SL1. Also, the
trans-splice site of ced-9 lies at the same
position as the 3' end of cyt-1, and there is an AAUAAA
signal within a few base pairs of the trans-splice
site (Fig. 1). This gene organization is
conserved in C. briggsae (10). A second
operon with this type of gene arrangement was recently cloned
by Korf et al. (12). The cks-1 gene is
trans spliced exclusively to SL1 even though it lies
immediately downstream of mes-6. In both examples,
polycistronic precursor RNA as well as both monocistronic mRNAs are
clearly detected on Northern blots. One possible explanation is that
the downstream gene in each case is expressed from an unidentified promoter within the coding sequence of the upstream gene instead of
from a shared upstream promoter. Thus, these would not be examples of a
novel class of operons, but of overlapping transcription units.
When the 3' end of such an upstream gene was formed, the trans-splice site of the downstream gene would be
destroyed, resulting in rapid decay of the uncapped downstream RNA.
If this hypothesis is correct, then the downstream mRNAs are
expressed exclusively from the unidentified promoter and not by
processing of the polycistronic precursor.
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
SL1 trans Splicing and 3'-End Formation
in a Novel Class of Caenorhabditis elegans
Operon

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References

View larger version (22K):
[in a new window]
FIG. 1.
Sequences of the polyadenylation/trans-splice
site regions of three SL1-type operons. Polyadenylation signals
and trans-splice signals are underlined. The sequences are
aligned at the sites of trans splicing. Upstream mRNA
sequences are in plain type, while downstream mRNA sequences
are in boldface. cyt-1/ced-9 sequences are from Hengartner
and Horvitz (10), and mes-6/cks-1 sequences are
from Korf et al. (12). The U1-70K sequence is from cosmid
K04G7, which was sequenced by the C. elegans Genome
Center (accession no. U21320).
If both upstream and downstream RNAs are expressed only from the same promoter, then the mechanism of processing of the precursor is not clear. In order for the downstream gene to be expressed, trans splicing must occur on the polycistronic precursor RNA. This would leave a free 3' end on the upstream RNA, which could either be polyadenylated or degraded. CPSF is able to promote efficient polyadenylation of a free 3' end in vitro (19). An alternative model is that each pre-mRNA could produce the mRNA from either the upstream or the downstream gene, but not both. In this model a pre-mRNA could either be trans spliced to form the downstream mRNA (with the upstream, presumably branched, portion discarded) or be cleaved and polyadenylated by CPSF-CstF, which would destroy the trans-splice site. Thus, 3'-end formation and trans splicing could be in direct competition, or trans splicing might be able to create a free 3' end that could then be polyadenylated. These two mechanisms are not mutually exclusive.
We present here the identification of a third example of this SL1-type operon. We have also created an artificial SL1-type operon, which exhibits the same properties in vivo as the endogenous examples. There is no space between the genes, and the downstream gene is trans spliced to SL1 instead of SL2. We have analyzed processing of this artificial operon by mutating the signals predicted to be involved.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Worm culture and RNA preparation. Worms were grown and maintained as described elsewhere (4, 24). Transgenic worms bearing extrachromosomal arrays were made by the method of Mello et al. (18) and Spieth et al. (23) by using the pRF5 rol-6 plasmid as a marker. The rol-6 null strain MT2597 was the parent strain in all cases. Mixed-stage populations of worms were heat shocked at 30°C for 1 h in water. Total RNA was prepared as described elsewhere (9).
Plasmids.
A 739-bp PCR product amplified from genomic DNA by
using Pfu DNA polymerase (Stratagene) and oligonucleotides
mes-6-Sal and cks-1PR was inserted into the StuI site of the
vector p
HSgpdvit (the plasmid pHS-1496 [23] with
the SalI site in the vector deleted [16])
to make pMGV-WT. This plasmid was used as a template for recombinant
PCRs (11) to generate mutant plasmids pMGV-
pA, pMGV-
ts, pMGV-
pA2, pMGV-
pAts, pMGV-
Utr, and
pMGV-
UtrDS. Pfu DNA polymerase was used for the first
round of PCR; Taq DNA polymerase (Gibco-BRL) was used for
the recombinant PCR. The following oligonucleotides were used
(mismatches from the wild-type sequence are lowercased): mes-6-Sal,
5'-CCTAATGACAATCGATAGCAACTTAC-3'; cks-1PR,
5'-GCACGTGACGCTCGGGAAGACTTC-3'; mes-6
pA(+),
5'-GATGCTTGTTAAcAccATGAATTATTTCAG-3'; mes-6
pA(
), 5'-AAATAATTCATggTgTTAACAAGCATCGGG-3'; cks-1
ts(+),
5'-TAATAAATGAATTATTTCAttGtCGCACCTTCTCACG-3'; cks-1
ts(
),
5'-GAAGGTGCGaCttAGAAATAATTCATTTTATTAACAAGC-3';
mes-6
pA2(+), 5'-GATGCTTGTTAAcAccATGccTTaTTTCAG-3';
mes-6
pA2(
), 5'-AAATAAggCATggTgTTAACAAGCATCGGG-3';
pAts(+), 5'-CTTGTTAAcAccATGAATTATTTCAttGTCGCACCTTCTC-3';
pAts(
), 5'-GAAGGTGCGACaaTGAAATAATTCATggTgTTAACAAGCATC-3';
mes-6
Utr(+), 5'-CTCACTCTTGTCTCATTCCCACCCGATGCTTGTTAATAAAATG-3';
mes-6
Utr(
), 5'-CATTT TATTAACAAGCATCGGGTGGGAATGAGACAAGAGTGAG-3'; mes-6
UtrDS(+), 5'-CTTTTTTTTCAATATTTTTTACCCGATGCTTGTTAATAAAATG-3'; and
mes-6
UtrDS(
), 5'-CATTTTATTAACAAGCATCGGGTAAAAAATATTGAAAAAAAAGAG-3'. The
mutant constructs were all sequenced before transformation. Due to the infidelity of the Taq polymerase, several unwanted single
nucleotide mismatches were observed, but unless they were in regions
predicted to be important for processing (e.g., splice site mutations)
or stability (e.g., creation of a premature stop codon), these were ignored.
RNase protection and primer extension analysis. RNase protection was carried out as described elsewhere (13) except that 20 µg of total RNA was treated with RNase-free DNase I prior to hybridization to the probe. Primer extension was also carried out as described elsewhere (13) with the primer cks1-PE (5'-GGCGTGAGAAGGTGCGACTC-3') in the presence of dideoxycytidine (ddC).
RT-PCR. Reverse transcription-PCR (RT-PCR) to determine the trans splicing specificity of U1-70K was carried out as described previously (29); the downstream primer was to nt 17906 to 17927 of cosmid K04G7, which is complementary to a sequence near the 5' end of the predicted U1-70K mRNA. The resulting RT-PCR product with SL1 or SL2 trans spliced at the predicted trans-splice site, 18233, would be 349 bp. RT-PCR products were electrophoresed, blotted, and probed with an oligonucleotide from 18100 to 18121 of K04G7.
For rapid amplification of 3' cDNA ends (3' RACE), total RNA was denatured at 65°C for 3 min prior to addition of reverse transcriptase (RT) buffer, nucleoside triphosphates, 3'20 primer [5'-GCGGCCGCAGATCTCGAG(T)20(G/A/C)-3'] and avian myeloblastosis virus RT (Promega). The 20-µl reaction mixture was incubated at 42°C for 1 h, then diluted 10-fold with water. Five microliters was used in a PCR with 3'20 as the downstream primer and mes/gpd-5' (5'-GCCACCAAGGCCTAATGACAGTCG-3') as the upstream primer. mes/gpd-5' crosses the border between gpd-2 and mes-6 in the vector and hence is unable to prime off the products of either endogenous gene. The products from 3' RACE were cloned into the pGEM-T vector (Promega) and sequenced by using primer SP6.| |
RESULTS |
|---|
|
|
|---|
A third SL1-type operon. In scanning the output of the C. elegans genome project for proteins involved in splicing, we discovered a presumptive operon containing the gene for the U1-70K snRNP protein. This gene is the third gene in a three-gene cluster; the two genes upstream are not clearly related to any other genes in the database. We noticed that the trans-splice site of the U1-70K gene (K04G7.10) is just downstream of an AAUAAA site and that there is no other 3'-end formation signal in the predicted 3' untranslated region (3' UTR) of the upstream gene (K04G7.11). Since this is the hallmark of the other two operons of this type (Fig. 1), we performed two experiments to determine the nature of the trans splicing of U1-70K and the site of 3'-end formation of K04G7.11. When we performed RT-PCR with an oligonucleotide equivalent either to the SL1 or to the SL2 spliced leader and an oligonucleotide in the U1-70K gene, we found that all trans splicing is to SL1 (Fig. 2). When we performed 3' RACE RT-PCR with an oligonucleotide in the K04G7.11 gene (data not shown), we found that all three clones sequenced represented instances of polyadenylation either 1 or 2 nt upstream of the trans-splice site and at an appropriate distance downstream of the AAUAAA signal (2) (Fig. 1).
|
An artificial SL1 operon. An artificial SL1-type operon was constructed and tested in vivo. This construct, depicted in Fig. 3A, is based on the gpd-2/gpd-3 operon described previously (13, 23). A 739-bp region of the mes-6/cks-1 operon, containing the 3' 394 bp of mes-6 and the 5' 345 bp of cks-1, was inserted into the 3' UTR of gpd-2 immediately after the stop codon (Fig. 3B). Thus, the 3' UTR of gpd-2 is replaced with that of mes-6, and the cks-1 coding region terminates within the 3' UTR of gpd-2. The gpd-2-gpd-3 intercistronic space and gpd-3 itself are unaffected. The entire three-gene operon is expressed under the control of the hsp-16-41 heat-shock promoter. The construct, pMGV-WT, was used to generate stable transgenic lines, and expression was induced by heat shock as described in Materials and Methods. Total RNA from these strains, before and after heat shock, was analyzed for expression of the operon as described previously (13). An RNAse protection probe covering the region shown in Fig. 3A protected the expected fragments (Fig. 4, lanes 1 and 2). The probe detects both endogenous and transgenic products, which are distinguishable by heat inducibility. Both mes-6 and cks-1 products were heat shock inducible, indicating that they are both derived from the polycistronic precursor RNA. Unprocessed precursor RNA, neither trans spliced nor cleaved, was also readily detectable.
|
|
|
|
3'-end formation occurs in the absence of trans
splicing.
The close apposition of the sites of trans
splicing and 3'-end formation suggests that the two processes could
occur in concert on the same pre-mRNA, resulting in production of
both mature mRNAs from a single processing event. In order to
determine whether 3'-end formation was dependent on trans
splicing, the trans-splice site was mutated to create
pMGV-
ts. The effects of the trans-splice site
mutation on expression of both the upstream and downstream genes
were examined. Transgenic strains were analyzed by RNAse protection
(Fig. 4, lanes 7 and 8). To our surprise, 3'-end formation was not
dependent on trans splicing. In strains bearing the
trans-splice site mutant construct, no heat-inducible band
at the position of the normal trans-spliced product was
found. Although we do not know what the novel band in lane 8 at about
210 bp is, it is almost certainly not an alternative
trans-spliced product, since no sequence even distantly
related to a trans-splice site is present in that region of
the mes-6 3' UTR (Fig. 3B). Even though no cks-1
product above background level was detected, the mes-6 3'
end appeared to form normally. In fact, 3'-end formation appears to be
more efficient, since polycistronic precursor RNA is significantly
reduced in these strains. We also determined the range of sites used
for 3'-end formation in the absence of a trans-splice site
by sequencing RT-PCR products. The distribution of sites was
indistinguishable from that seen with the wild-type construct (Fig. 6).
We conclude that 3'-end formation can occur in the absence of
trans splicing in this operon and that in an otherwise wild-type construct, the trans-splice site does
not influence the site of 3'-end formation. Furthermore, it appears that RNA that would otherwise have been trans spliced or not
processed at all is efficiently cleaved by the 3'-end formation
machinery when the trans-splice site is eliminated.
trans splicing without 3'-end formation.
In order
to determine whether trans splicing is influenced by the
presence of a closely juxtaposed 3'-end formation signal, the
mes-6 polyadenylation signal, AAUAAA, was mutated
(to AACACC) to create pMGV-
pA (Fig. 3B). Strangely,
the poly(A) signal mutation reduced, but did not abolish, 3'-end
formation of the upstream gene (Fig. 4, lanes 3 and 4). RNase
protection analysis showed that trans splicing occurred at
normal levels in the
pA mutant strains, and primer extension showed
that cks-1 was still trans spliced exclusively to
SL1 (data not shown). In the
pA mutant we identified a possible
cryptic polyadenylation signal, CAUGAA, immediately
downstream of the AAUAAA (Fig. 3B), which could have been used for residual 3'-end formation. To test this idea, we constructed a double poly(A) site mutation (
pA2) (Fig. 3B), which did effectively eliminate 3'-end formation (Fig. 4, lanes 5 and 6).
trans splicing still occurred at approximately the same
level as that in the wild type, and polycistronic precursor RNA still accumulated. This shows that trans splicing is not
significantly influenced by a nearby 3'-end formation signal.
Influence of the trans-splice site on the site of
3'-end formation.
To test whether mutation of the primary
AAUAAA resulted in a new site of 3'-end formation directed
by the hypothetical remaining signal 5 bp downstream, we sequenced
10 RT-PCR clones from RNA isolated from transgenic strains carrying the
pA mutant construct. If 3'-end formation was occurring by the normal
CPSF-dependent mechanism in the strain with only a weak CPSF binding
site 5 bp downstream of the normal site, we would perhaps expect
these 3' ends to be located about 5 bp downstream of the location
found in the wild-type strain. However, when we measured the
locations of mes-6 3' ends in the
pA mutant, we
found a distribution similar to that shown by the wild-type construct
(Fig. 6). One possible explanation for this distribution would be that
these 3' ends were actually generated by trans splicing
rather than by the conventional CPSF-CstF-dependent mechanism. In
this case we would expect the site of cleavage to have remained
the same. Thus, this result suggests that the site of cleavage
may have been determined, or at least influenced, by the
trans-splice site.
pA and
ts mutations. Simultaneous mutation of the AAUAAA and the
trans-splice signal (
pAts) resulted in the accumulation
of precursor RNA and polyadenylated mes-6 mRNA, but no
cks-1 mRNA (Fig. 4, lanes 9 and 10). Sequencing of the
3' ends of mes-6 RT-PCR clones from this mutant revealed a
change in the distribution of poly(A) sites. All nine cDNAs now lay 3 or 4 nt downstream of the original site of polyadenylation (Fig.
6). This is consistent with 3'-end formation occurring in the regular
fashion, with cleavage directed by the nonconsensus
polyadenylation site when the trans-splice site is mutated. The difference in poly(A) site distribution between the
pA and the
pAts mutant suggests that in
pA, the
trans-splice site is influencing the site of cleavage. Since
trans splicing does result in cleavage, our data are
consistent with a model in which the free 3' end created by
trans splicing is polyadenylated, at least for 6 of the 10 cDNAs we sequenced. Although the close proximity of the
trans-splice site and polyadenylation signal in this system
makes it difficult to mutate the trans-splice site without
risking a direct effect on sequences required for polyadenylation, the
ts mutation did not change the site of 3'-end formation in the
absence of the
pA mutation. Therefore, it is very unlikely that
there is a direct effect of the
ts mutation on the choice of
cleavage sites.
Competition between trans splicing and 3'-end
formation.
A comparison of the wild type with the
ts mutant
(Fig. 4) demonstrates clearly a strong competition between 3'-end
formation and trans splicing. The level of 3'-end formation
goes up dramatically, and the level of unprocessed precursor is
significantly reduced, when the trans-splice site is
mutated. This suggests that trans splicing reduces the level
of substrate available for 3'-end formation. The fact that unprocessed
precursor accumulates when all sites are intact but does not when
the trans-splice site is mutated suggests that the presence
of a trans-splice site somehow interferes with 3'-end
formation even when it does not lead to the formation of a
trans-spliced product.
pA2 mutant does not show an increase in
trans splicing or a decrease in unprocessed precursor when
the poly(A) sites are eliminated, suggesting that 3'-end formation is
not reducing the level of substrate available for trans
splicing. We interpret these results to indicate that the
trans-splice site is normally occupied first, but not all of
the precursor is trans spliced. The formation of 3' ends
then occurs on a fraction of the substrate that was not
trans spliced.
Functions of the 3' UTR polypyrimidine tract.
As all three
examples of SL1-type operons have extensive polypyrimidine
tracts in the 3' UTRs of the upstream gene, we deleted a portion of
this region in the artificial operon (
Utr [Fig. 3B]) and
measured the effect on processing (Fig.
7). A 58-bp deletion in the
mes-6 3' UTR results in accumulation of polycistronic
precursor RNA but no mes-6 3'-end product (Fig. 7). Thus, it
appears that there are sequences within the long poly(Y) tract that
are required for the accumulation of 3'-end product. These sequences
could be needed either for 3'-end formation or for the stability of the
product. trans splicing further downstream was also
significantly reduced by the
Utr mutation. (The band just below the
trans-spliced product in Fig. 7, lane 4, is of unknown
origin, but it is not a trans-spliced product, based
on primer extension results which are not shown.) In order to
further define the sequences required, another deletion, half the size
of the original, was made (
UtrDS [Fig. 3B]). This mutant
apparently has a phenotype similar to that of the mutant with the
larger deletion
most of the RNA appears to be unprocessed precursor
(Fig. 7, lanes 5 and 6), although
UtrDS does show a small
accumulation of mes-6 3' end.
|
| |
DISCUSSION |
|---|
|
|
|---|
A second class of operon in C. elegans. In the major class of C. elegans operons, there is an intercistronic region of 100 to 400 bp between the site of 3'-end formation of the upstream gene and the trans-splice site of the downstream gene. In this type of operon, SL2 or a mixture of SL2 and SL1 is trans spliced to the downstream mRNA. Furthermore the pre-mRNAs are processed in such a way as to produce mature mRNAs from a single polycistronic precursor. Here we demonstrate the existence of a novel type of C. elegans operon in which there is no space between the genes and the downstream gene is trans spliced exclusively to SL1. This type of operon is also different from the major class in that our results suggest the possibility that a single precursor may produce either the upstream or the downstream product, but not both. This is because the trans-splice site and the 3'-end formation site are so close that when 3'-end formation occurs, the precursor for trans splicing is destroyed. One possibility had been that the downstream mRNA was made from an internal promoter within the upstream gene. However, our results demonstrate that the downstream mRNA, at least, can be made from a polycistronic precursor when it is expressed from a heat shock promoter more than 1.5 kb upstream. When it is produced from such an upstream promoter, at a distance which in the majority class of C. elegans operon results in SL2-specific trans splicing (13), we found that it was nevertheless trans-spliced exclusively to SL1 (Fig. 5). This result argues strongly that the SL1-trans-spliced products are indeed generated from polycistronic precursor RNAs.
Relationship between 3'-end formation and trans splicing. Our data are most consistent with a model in which most pre-mRNAs from this type of operon produce either an upstream mRNA or a downstream mRNA, and the rest of the pre-mRNA is destroyed. In order for the downstream RNA to be made, trans splicing must occur before cleavage and polyadenylation of the upstream gene, because cleavage downstream of the AAUAAA would destroy the trans-splice site of the downstream gene. Our results suggest that trans splicing does indeed interfere with formation of the upstream mRNA, presumably because it reduces the level of precursor available for CPSF-CstF-dependent 3'-end formation. Polyadenylation levels increase significantly and unprocessed precursor decreases significantly when the trans-splice site is mutated, indicating an inhibitory effect of the trans-splicing event on 3'-end formation (Fig. 4). Interestingly, the converse does not appear to be true. When the poly(A) signals are mutated, the level of trans splicing does not increase, and precursor that has been neither trans spliced nor cleaved and polyadenylated remains (Fig. 4). This suggests a model in which the precursor is first subjected to trans splicing, but some of it somehow escapes this process. Then a portion of the remaining precursor is cleaved and polyadenylated in a CPSF-dependent process.
Why is SL1 used for trans splicing at these internal trans- splice sites? In most operons, trans splicing occurs 100 to 400 bp downstream of a conventional 3'-end formation site. The structure of the actual precursor for this trans-splicing event, which utilizes the SL2 snRNP as a donor, is not known. It may already be cleaved, or trans splicing and cleavage-polyadenylation may occur cooperatively and simultaneously. In the new class of operons studied here, SL1 snRNP is used as a splice donor. This snRNP has previously been shown to be used at outrons, intron-like sequences with a cap at the 5' end and a trans-splice site at the 3' end (2). We argue above that in the SL1-type operons, trans splicing occurs on the polycistronic RNA, so the entire upstream gene may be recognized as an outron, resulting in SL1 trans splicing.
Does the free 3' end created by trans splicing
sometimes get polyadenylated?
While there is undeniably
competition between the 3'-end formation machinery and the
trans-splicing machinery for processing at the sites where
the two genes meet, our data are also consistent with a role for
trans splicing in generating a free 3' end, which can then
be polyadenylated as long as it has a CPSF binding site. There is
evidence in mammalian systems that both CPSF and CstF specify the site
of 3'-end formation. A change in the relative positions of the CPSF and
CstF binding sites generally results in a concomitant shift in the site
of cleavage (5). This is apparently due to a requirement for
a minimal distance between the CPSF binding site and the cleavage site.
In the
pA mutant, the CPSF binding site has effectively been moved
downstream by 5 nt, but we see essentially no alteration in
the site of cleavage in the presence of an active
trans-splice signal (Fig. 6). However, upon mutation of the
trans-splice signal, there is an accompanying shift in the
site of polyadenylation. This is consistent with CPSF allowing
polyadenylation of the free 3' end generated by trans
splicing. We propose that in these operons polyadenylation may
occur both by the usual CstF-dependent mechanism in competition with
trans splicing and also by a second,
trans-splicing-dependent and perhaps CstF-independent mechanism.
The importance of a long upstream polypyrimidine tract. We have identified an extensive polypyrimidine tract in the 3' UTR of each of the three operons of this type, and we have shown that this region of mes-6 is required for processing. When either the entire sequence or just its downstream portion is deleted, levels of both cks-1 and mes-6 mRNAs are dramatically reduced (Fig. 7). The effect on mes-6 mRNA is not due to a secondary effect of inhibition of trans splicing, since inhibition of trans splicing by elimination of the trans-splice site did not reduce the level of 3'-end formation (Fig. 4). While the lack of downstream product must be attributed to a direct effect on trans splicing, the dramatic reduction of mes-6 mRNA levels could be due either to decreased stability of the message or to failure to form 3' ends.
Polypyrimidine tracts have previously been implicated in both cis and trans splicing. cis splicing in mammalian systems requires a polypyrimidine tract downstream of the branch site, which interacts with U2AF (21). In C. elegans no such element has been identified, but the 3' splice site has an unusually long and well-conserved consensus, UUUUCAG/R, which has been hypothesized to substitute for the polypyrimidine tract (30). In trypanosomes, trans splicing and polyadenylation of polycistronic transcripts are directly coupled (14). trans splicing requires a polypyrimidine tract in the intercistronic region (17), and 3'-end formation upstream requires trans splicing (15). Deletion analysis of part of the 84-nt polypyrimidine tract of the mes-6/cks-1 operon indicates that, as in trypanosomes, a polypyrimidine tract in this type of C. elegans operon plays a crucial role in trans splicing and possibly in 3'-end formation as well. It should be emphasized here that in no other case has such a far-upstream polypyrimidine tract been shown to play a role in trans splicing, nor does an upstream polypyrimidine tract generally perform a role in 3'-end formation in animals. However, pyrimidine-rich elements have been identified as upstream efficiency elements required for polyadenylation of viral mRNAs and a few cellular RNAs (3, 20, 22, 25), and the polypyrimidine tract in the mes-6 3' UTR could be performing an analogous function in its 3'-end formation. The mes-6 polyadenylation signal is not optimal by mammalian standards, as it lacks any U-rich or GU-rich downstream sequence element at an appropriate position to act as a CstF binding site. Also, trans splicing would result in cleavage and loss of any downstream sequences. One hypothesis to explain the lack of a downstream sequence element is that the upstream pyrimidine tract is acting as an upstream efficiency element to promote mes-6 3'-end formation. In the case of the mammalian C2 complement poly(A) signal, there is an upstream polypyrimidine tract which has been shown to interact both with polypyrimidine tract binding protein and with CstF, which binds cooperatively with CPSF (19a). A similar role could be performed by the extensive poly(Y) tracts in the 3' UTRs of the SL1-type operons. We cannot rule out the possibility that the pyrimidine-rich region in the 3' UTR is required for mes-6 mRNA stability. A pyrimidine-rich element has been identified as a constitutive stabilizer of the human
-globin mRNA (26, 27).
Deletion of the stabilizer element in this mRNA results in its
becoming highly unstable. Further experiments are required to elucidate
the role of the pyrimidine tract in trans splicing of
cks-1 and to determine whether it is required for the
stability of the mes-6 message or is acting as an upstream
polyadenylation element.
Conclusions. We have analyzed a novel class of C. elegans operon, which we call SL1-type. These operons are different from the majority, SL2-type operons in several interesting ways: (i) the downstream genes are trans spliced exclusively by SL1; (ii) there is no intercistronic region, and the 3'-end formation signal, AAUAAA, is only a few base pairs upstream of the trans-splice site, so the two processes compete; (iii) there is an unusually long polypyrimidine tract in the 3' UTR of the upstream gene, which is required for accumulation of both upstream and downstream mRNAs; (iv) these operons appear to be designed to produce only upstream mRNA or only downstream mRNA, but usually not both, from a single precursor. It is not yet clear, given the small number of SL1-type operons that we know of, whether the genes in these operons have a relationship with one another that makes this a functionally significant gene arrangement.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to Susan Strome and Ian Korf for communication of their results prior to publication and to our colleagues in the lab and Susan Strome for their helpful comments on the manuscript.
This work was supported by research grant GM42432 from the National Institute of General Medical Sciences.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Biochemistry and Molecular Genetics, University of Colorado Health Sciences Center, 4200 E. 9th Ave., Denver, CO 80262. Phone: (303) 315-8181. Fax: (303) 315-8215. E-mail: blumentt{at}essex.uchsc.edu.
Present address: Department of Molecular Genetics and Microbiology,
RWJ Medical School, UMDNJ, Piscataway, NJ 08854.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Blumenthal, T. Unpublished data. |
| 2. | Blumenthal, T., and K. Steward. 1997. RNA processing and gene structure, p. 117-145. In D. Riddle, T. Blumenthal, B. Meyer, and J. Priess (ed.), C. elegans II. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 3. |
Brackenridge, S.,
H. L. Ashe,
M. Giacca, and N. J. Proudfoot.
1997.
Transcription and polyadenylation in a short human intergenic region.
Nucleic Acids Res.
25:2326-2335 |
| 4. |
Brenner, S.
1974.
The genetics of Caenorhabditis elegans.
Genetics
77:71-94 |
| 5. |
Chen, F.,
C. C. MacDonald, and J. Wilusz.
1995.
Cleavage site determinants in the mammalian polyadenylation signal.
Nucleic Acids Res.
23:2614-2620 |
| 6. |
Colgan, D. F., and J. L. Manley.
1997.
Mechanism and regulation of mRNA polyadenylation.
Genes Dev.
11:2755-2766 |
| 7. | Conrad, R., K. Lea, and T. Blumenthal. 1995. SL1 trans-splicing specified by AU-rich synthetic RNA inserted at the 5' end of Caenorhabditis elegans pre-mRNA. RNA 1:164-170[Abstract]. |
| 8. |
Conrad, R.,
R. F. Liou, and T. Blumenthal.
1993.
Functional analysis of a C. elegans trans-splice acceptor.
Nucleic Acids Res.
21:913-919 |
| 9. |
Conrad, R. C.,
J. Thomas,
J. Spieth, and T. Blumenthal.
1991.
Insertion of part of an intron into the 5' untranslated region of a Caenorhabditis elegans gene converts it into a trans-spliced gene.
Mol. Cell. Biol.
11:1921-1926 |
| 10. | Hengartner, M. O., and H. R. Horvitz. 1994. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76:665-676[Medline]. |
| 11. |
Higuchi, R.,
B. Krummel, and R. R. Saiki.
1988.
A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions.
Nucleic Acids Res.
16:7351-7367 |
| 12. | Korf, I., Y. Fan, and S. Strome. The polycomb group in Caenorhabditis elegans and maternal control of germline development. Development 13:2469-2478. |
| 13. | Kuersten, R. S., K. Lea, M. MacMorris, J. Spieth, and T. Blumenthal. 1997. Relationship between 3' end formation and trans-splicing in polycistronic Caenorhabditis elegans pre-mRNA processing. RNA 3:269-278[Abstract]. |
| 14. |
LeBowitz, J. H.,
H. Q. Smith,
L. Rusche, and S. M. Beverly.
1993.
Coupling of poly(A) site selection trans-splicing in Leishmania.
Genes Dev.
7:996-1007 |
| 15. |
Lopez-Estrano, C.,
C. Tschudi, and E. Ullu.
1998.
Exonic sequences in the 5' untranslated region of -tubulin mRNA modulate trans splicing in Trypanosoma brucei.
Mol. Cell. Biol.
18:4620-4628 |
| 16. | MacMorris, M. Unpublished data. |
| 17. |
Matthews, K. R.,
C. Tschudi, and E. Ullu.
1994.
A common pyrimidine rich motif governs trans-splicing and polyadenylation of polycistronic pre-mRNA in trypanosomes.
Genes Dev.
8:491-501 |
| 18. | Mello, C., J. Kramer, D. Stinchcomb, and V. Ambros. 1991. Efficient gene transfer in C. elegans: extrachromosomal maintenance and integration of transforming sequences. EMBO J. 10:3959-3970[Medline]. |
| 19. | Moore, C. L., and P. A. Sharp. 1985. Accurate cleavage and polyadenylation of exogenous RNA substrate. Cell 41:845-855[Medline]. |
| 19a. |
Moreira, A.,
Y. Takagaki,
S. Brackenridge,
M. Wollerton,
J. L. Manley, and N. J. Proudfoot.
1998.
The upstream sequence of the C2 complement poly(A) signal activates mRNA 3' end formation by two distinct mechanisms.
Genes Dev.
12:2522-2534 |
| 20. | Moreira, A., M. Wollerton, J. Monks, and N. J. Proudfoot. 1995. Upstream sequence elements enhance poly(A) site efficiency of the C2 complement gene and are phylogenetically conserved. EMBO J. 14:3809-3819[Medline]. |
| 21. | Ruskin, B., P. D. Zamore, and M. R. Green. 1987. A factor, U2AF, is required for U2 snRNP binding and splicing complex assembly. Cell 52:207-219. |
| 22. |
Schek, N.,
C. Cooke, and J. C. Alwine.
1992.
Definition of the upstream efficiency element of the simian virus 40 late polyadenylation signal by using in vitro analyses.
Mol. Cell. Biol.
12:5386-5393 |
| 23. | Spieth, J., G. Brooke, S. Kuersten, K. Lea, and T. Blumenthal. 1993. Operons in C. elegans: polycistronic mRNA precursors are processed by trans-splicing of SL2 to downstream coding regions. Cell 73:521-532[Medline]. |
| 24. | Sulston, J., and J. Hodgkin. 1988. Methods, p. 587-606. In W. B. Wood (ed.), The nematode Caenorhabditis elegans. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 25. |
Valsamakis, A.,
N. Schek, and J. C. Alwine.
1992.
Elements upstream of the AAUAAA within the human immunodeficiency virus polyadenylation signal are required for efficient polyadenylation in vitro.
Mol. Cell. Biol.
12:3699-3705 |
| 26. |
Weiss, I., and S. A. Liebhaber.
1994.
Erythroid cell-specific determinants of -globin mRNA stability.
Mol. Cell. Biol.
14:8123-8132 |
| 27. |
Weiss, I., and S. A. Liebhaber.
1995.
Erythroid cell-specific mRNA stability elements in the 2-globin 3' nontranslated region.
Mol. Cell. Biol.
15:2457-2465[Abstract].
|
| 28. | Williams, C. J., and T. Blumenthal. Unpublished data. |
| 29. | Zorio, D. A. R., N. N. Cheng, T. Blumenthal, and J. Spieth. 1994. Operons represent a common form of chromosomal organization in C. elegans. Nature (London) 372:270-272[Medline]. |
| 30. | Zorio, D. A. R., K. Lea, and T. Blumenthal. 1997. Cloning of Caenorhabditis U2AF65: an alternatively spliced RNA containing a novel exon. Mol. Cell. Biol. 17:946-953[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|